By Catherine Cheney July 19, 2018 DAVIS, Calif. — The team at Evolve BioSystems, a privately held microbiome company in Davis, California, spends a lot of time talking about a woman named Sloane. She appears in a large cardboard poster Read More
Year: 2018
Devex: Why investors are looking at Indian ag-tech startups
By Catherine Cheney November 20, 2018 SAN FRANCISCO — When agribusinesses buy crops from smallholder farmers, they tend to send agents to the field, who walk the periphery of plots, take pictures of crops, and identify issues such as pests, Read More
Press Release: CropIn Technology raises $8 million from Chiratae Ventures, Gates Foundation
By Aakanksha Ahuja November 20, 2018 New Delhi: CropIn Technology Solutions Pvt. Ltd, which provides agri-businesses with farm management software and mobile apps, has raised $8 million in a Series B funding round from Chiratae Ventures (formerly IDG Ventures) and Read More
Business Wire: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates
December 24th, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced that it has raised $27 million in a Series C financing Read More
Devex: Q&A: How Gates’ Strategic Investment Fund gets companies to take on global health
By Catherine Cheney August 16, 2018 SEATTLE — When Andrew Farnum used to speak about work with his wife, a program officer focused on global health at the Bill & Melinda Gates Foundation, he would ask himself how he might Read More
Press Release: Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
June 12, 2018 DAVIS, Calif., June 13, 2018 /PRNewswire/ — Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, Read More
The Sunday Morning Herald: Australian not-for-profit wins unprecedented approval for blindness drug
By Latika Bourke July 22, 2018 London: An Australian company has won unprecedented US approval for a new drug to treat the second most common preventable cause of blindness in the world. In the process, Medicines Development for Global Health, Read More
The Economic Times: Stellapps bags $14 million in a round led by Gates Foundation, others
By Shashwati Shankar May 31, 2018 BENGALURU: Omnivore-backed agritech startup Stellapps Technologies has raised $14 million in one of the largest equity funding rounds led by Bill and Melinda Gates Foundation and IndusAge Partners, among others. Bengaluru based Stellapps Technologies, Read More
Press Release: IndusAge, ABB, Gates Foundation invest in Bengaluru-based Stellapps
June 1, 2018 Bengaluru: Bengaluru-based Stellapps Technologies has received Series B investment round of $14 million led by IndusAge Partners and included new investors Qualcomm Ventures, ABB, and the Bill & Melinda Gates Foundation. ABB has invested through its venture capital Read More
Fierce Biotech: Genentech forms $1B discovery collaboration with soil-prospector Lodo Therapeutics
By Conor Hale May 9, 2018 Genentech signed a broad, open-ended drug discovery collaboration with Lodo Therapeutics that could be worth nearly $1 billion, focused on deriving unique, natural products from the microbial DNA found in soil. The drugmaker plans Read More